CLINICAL TRIAL: ACTION TO CONTROL CARDIOVASCULAR RISKS IN DIABETES (ACCORD)

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 ACCORD试验旨在评估控制血糖、血压和血脂(血液中的脂肪)的不同方法对降低成人2型糖尿病患者心脏病和中风风险的效果。共有10,000名参与者将从美国和加拿大的大约60个地点登记参加。主要结果是首次发生重大心血管疾病事件。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The ACCORD Trial is designed to evaluate the effect of different ways to control blood sugar, blood pressure, and blood lipids (fats in the blood) to reduce the risk of heart disease and stroke in adults with Type 2 (adult-onset) diabetes. A total of 10,000 participants will be enrolled from approximately 60 sites across the USA and Canada. The primary outcome is the first occurrence of a major cardiovascular disease event.